SCHEMBL2813666

SCHEMBL2813666

CC(C)(CNC(=O)c1n[nH]c2ccccc12)c1ccc(N)cc1Cl

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.49
KDM4E B2RXH2 4/20 0.49
RAB9A P51151 3/20 0.48
GAA P10253 2/20 0.48
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
EPHB3 P54753 1/20 0.47
YTHDC1 Q96MU7 1/20 0.47
CSNK2A1 P68400 1/20 0.47
NPC1 O15118 3/20 0.47
ALDH1A1 P00352 2/20 0.47
L3MBTL1 Q9Y468 1/20 0.45
MAPK10 P53779 1/20 0.45
HSD17B10 Q99714 1/20 0.45
SIRT1 Q96EB6 1/20 0.43
HTR1A P08908 1/20 0.43
DRD2 P14416 1/20 0.43
HTR2A P28223 1/20 0.43
FLT3 P36888 3/20 0.43
CCNA2 P20248 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2817666 0.84 GSK3B (0.48) SMN1; SMN2KDM4ERAB9AGAAMEN1
SCHEMBL2815569 0.79 HDAC3 (0.46) KDM4EALDH1A1HSD17B10DRD2HTR2A
SCHEMBL2818030 0.78 NTRK1 (0.52) SMN1; SMN2KDM4ERAB9AGAACSNK2A1
SCHEMBL14314019 0.77 KDM4E (0.65) SMN1; SMN2KDM4ERAB9AGAAMEN1
SCHEMBL20181950 0.76 KDM4E (0.64) SMN1; SMN2KDM4ERAB9AGAAMEN1
SCHEMBL30068590 0.75 KDM4E (0.62) SMN1; SMN2KDM4ERAB9AGAAMEN1
SCHEMBL2817651 0.73 NR1H4 (0.44) SMN1; SMN2MEN1KMT2AALDH1A1HSD17B10
SCHEMBL2814896 0.71 HDAC3 (0.46) KDM4EGAAALDH1A1HSD17B10DRD2
SCHEMBL950894 0.69 NPC1 (0.68) SMN1; SMN2KDM4ERAB9AGAAMEN1
SCHEMBL38655498 0.69 YTHDC1 (0.71) SMN1; SMN2KDM4ERAB9AGAAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100249123-A1 NOVEL BENZAMIDE DERIVATIVES AS MODULATORS OF THE FOLLICLE STIMULATING HORMONE ADDEX PHARMA SA (CH) 2010-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100249123-A1 NOVEL BENZAMIDE DERIVATIVES AS MODULATORS OF THE FOLLICLE STIMULATING HORMONE FSHR, GNRHR, SHBG SMN1; SMN2 4686/4885KDM4E 1395/4885RAB9A 1404/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.